Peter Boström
peter.bostrom@utu.fi |
- Aberrantly glycosylated PSMA in urine as a potential marker for prostate cancer (2026)
- Clinica Chimica Acta
- Can Radiomics Based Models Survive Across MRI Scanners? (2026)
- Lecture Notes in Networks and Systems
- Impact of asymptomatic bacteriuria on the outcomes and tolerability of Bacillus Calmette–Guérin immunotherapy (2026)
- Scandinavian Journal of Urology
- Radical cystectomy practice patterns in the Nordic countries: results from the prospective NorCys study (2026)
- Scandinavian Journal of Urology
- Accuracy of cognitive vs software‐guided MRI‐targeted biopsy in predicting final grading at prostatectomy (2025)
- BJU International
- Cross-cultural adaptation and psychometric validation of the Finnish version of the Expanded Prostate Cancer Index Composite-26 for patients with localised prostate cancer (2025)
- Scandinavian Journal of Urology
- High‐Sensitivity Detection of Urinary Extracellular Vesicles With Upconverting Nanoparticle‐Based Lateral Flow Immunoassay (2025)
- Journal of Extracellular Biology
- Improved diagnostic performance of a phage display antibody-assisted intact free PSA assay as used in the four kallikrein concept applied to the IMPROD/multi-IMPROD study (2025)
- Clinica Chimica Acta
- Is histological grade a useful parameter in muscle-invasive urothelial bladder cancer? Results from a multicenter study on the impact of different grading systems on disease-free survival after upfront radical cystectomy (2025)
- World Journal of Urology
- Long‐Term Risk of Clinically Significant Prostate Cancer in Biopsy‐Negative Patients With Baseline Biparametric Prostate MRI (2025)
- Journal of Magnetic Resonance Imaging



